Cannara Biotech Inc (LOVE) - Total Liabilities

Latest as of November 2025: CA$62.63 Million CAD ≈ $45.31 Million USD

Based on the latest financial reports, Cannara Biotech Inc (LOVE) has total liabilities worth CA$62.63 Million CAD (≈ $45.31 Million USD) as of November 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Cannara Biotech Inc - Total Liabilities Trend (2018–2025)

This chart illustrates how Cannara Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. See LOVE working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Cannara Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Cannara Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Kyeryong Const KO:013580	Korea	₩2.23 Trillion
HYUNDAI FEED Inc KQ:016790	Korea	₩28.17 Billion
Caisse Régionale du Crédit Agricole Alpes Provence PA:CRAP	France	€23.14 Billion
Grange Resources Ltd AU:GRR	Australia	AU$248.51 Million
ENIGMATIG LIMITED NYSE MKT:EGG	USA	$1.73 Million
Minaurum Silver Inc. V:MGG	Canada	CA$1.43 Million
ADC Therapeutics SA NYSE:ADCT	USA	$507.87 Million
RiTdisplay Corp TW:8104	Taiwan	NT$5.23 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down Cannara Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Cannara Biotech Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.70	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.56	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cannara Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cannara Biotech Inc (2018–2025)

The table below shows the annual total liabilities of Cannara Biotech Inc from 2018 to 2025.

Year	Total Liabilities	Change
2025-08-31	CA$66.43 Million ≈ $48.05 Million	-0.51%
2024-08-31	CA$66.77 Million ≈ $48.30 Million	+8.08%
2023-08-31	CA$61.78 Million ≈ $44.69 Million	+4.92%
2022-08-31	CA$58.88 Million ≈ $42.59 Million	+110.99%
2021-08-31	CA$27.91 Million ≈ $20.19 Million	+69.28%
2020-08-31	CA$16.49 Million ≈ $11.93 Million	-9.29%
2019-08-31	CA$18.17 Million ≈ $13.15 Million	+28.73%
2018-08-31	CA$14.12 Million ≈ $10.21 Million	--

About Cannara Biotech Inc

V:LOVE Canada Drug Manufacturers - Specialty & Generic

Market Cap

$126.80 Million

CA$175.28 Million CAD

Market Cap Rank

#18380 Global

#604 in Canada

Share Price

CA$1.83

Change (1 day)

-2.14%

52-Week Range

CA$1.27 - CA$1.98

All Time High

CA$3.05